Transforming growth factor beta 2 (TGFbeta 2) produces effective pleurodesis in sheep with no systemic complications
Open Access
- 1 December 2000
- Vol. 55 (12) , 1058-1062
- https://doi.org/10.1136/thorax.55.12.1058
Abstract
BACKGROUND We have recently shown that transforming growth factor (TGF)β2induces effective pleurodesis in rabbits. However, rabbits have a thin pleura while humans have a thick visceral pleura. The effect of intrapleural administration of TGFβ2 in animals with a thick pleura and its associated systemic effects have not been investigated. This study was undertaken (1) to develop a new animal model for the study of pleurodesis using sheep which have a thick pleura resembling that of humans; (2) to study the efficacy of TGFβ2 as a pleurodesis agent in the sheep model; and (3) to assess whether histological changes occur in extrapulmonary organs after intrapleural administration of TGFβ2. METHODS Twelve sheep were divided into four groups and were given a single intrapleural injection of TGFβ2 in a concentration of 1.0 μg/kg, 0.5 μg/kg, 0.25 μg/kg or 0.125 μg/kg to the right pleural cavity via a chest tube. The left pleural cavity served as the control. Any pleural fluid that accumulated after the intrapleural TGFβ2 injection was collected and analysed. The degree of pleurodesis was graded from 1 (no adhesions) to 8 (complete symphysis >50% of chest wall) at day 14 when the sheep were killed. Biopsy specimens were taken from the lungs and extrapulmonary organs. RESULTS All sheep that received ⩾0.25 μg/kg TGFβ2 developed excellent pleurodesis (score = 8) while those that received 0.125 μg/kg had a median score of 6. The pleurodesis score did not exceed 2 in the control (left) side of any sheep. Sheep receiving ⩾0.50 μg/kg TGFβ2 developed large exudative pleural effusions while those receiving a lower dose did not. The production of effusions neither hindered nor was necessary for inducing pleurodesis. There were no significant fibrotic changes in any of the extrapulmonary organs. CONCLUSION Intrapleural injection of 0.25–1.0 μg/kg TGFβ2 produces excellent pleurodesis in a new sheep model with no evidence of extrapulmonary fibrosis.Keywords
This publication has 28 references indexed in Scilit:
- Systemic Distribution of Talc After Intrapleural Administration in RatsChest, 1999
- Talc-induced inflammation in the pleural cavityEuropean Respiratory Journal, 1998
- Talc pleurodesis: Talc slurry versus thoracoscopic talc insufflation in a porcine modelThe Annals of Thoracic Surgery, 1996
- Comparison of Silver Nitrate and Tetracycline as Pleural Sclerosing Agents in RabbitsChest, 1995
- Tumour necrosis factor-α and nitric oxide, determined as nitrite, in malignant pleural effusionRespiratory Medicine, 1994
- Transforming Growth Factor β in Tissue FibrosisNew England Journal of Medicine, 1994
- Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β2Journal of Neuroimmunology, 1993
- Purification of transforming growth factors β1 and β2 from bovine bone and cell culture assaysPublished by Elsevier ,1991
- The structure of the parietal pleura and its relationship to pleural liquid dynamics in sheepThe Anatomical Record, 1984
- Structure, blood supply, and lymphatic vessels of the sheep's visceral pleuraJournal of Anatomy, 1982